Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02459964 · ClinicalTrials.gov registry record · Phase 4
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
A Phase 4 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
NCT02459964: Completed Phase 4 study, sponsored by M.D. Anderson Cancer Center.
NCT02459964 is a Phase 4 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 84 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02459964, a Phase 4 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to compare fentanyl nasal spray with a standard drug given by vein (hydromorphone hydrochloride) to help reduce pain related to cancer in patients coming to the emergency department.
Primary Outcome
The median change in Numeric Rating Scale (NRS) pain intensity scores (assessed on an 11-point Likert scale with 0 = no pain and 10 = worst pain) from randomization, estimate of treatment initiation, to one hour post-treatment calculated for both treatment arms.
Interventions
- DRUG Hydromorphone Hydrochloride
- BEHAVIORAL Phone Call
- DRUG Fentanyl Nasal Spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2015-09-14 |
| Est. Completion | 2020-06-21 |
| Phase | Phase 4 |
What the finished NCT02459964 record still lists
NCT02459964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 3 interventions - of which Hydromorphone Hydrochloride is the first listed.
NCT02459964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02459964 about?
NCT02459964 is a clinical study titled "Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain". The goal of this clinical research study is to compare fentanyl nasal spray with a standard drug given by vein (hydromorphone hydrochloride) to help reduce pain related to cancer in patients coming to the emergency department.
What is the current status of trial NCT02459964?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2015-09-14. Estimated completion is 2020-06-21.
What interventions are being tested in trial NCT02459964?
The interventions under investigation include: Hydromorphone Hydrochloride (DRUG), Phone Call (BEHAVIORAL), Fentanyl Nasal Spray (DRUG).
Who is sponsoring clinical trial NCT02459964?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02459964's enrollment target sits among peer trials
84 929th of 2000 higher than 1,064 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI